Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to post $29.93 billion in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Walgreens Boots Alliance’s earnings. The highest sales estimate is $30.66 billion and the lowest is $28.01 billion. Walgreens Boots Alliance posted sales of $28.64 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 4.5%. The business is scheduled to report its next quarterly earnings report on Thursday, October 19th.

According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year sales of $29.93 billion for the current financial year, with estimates ranging from $115.14 billion to $118.78 billion. For the next fiscal year, analysts anticipate that the business will report sales of $127.65 billion per share, with estimates ranging from $120.46 billion to $133.53 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. Walgreens Boots Alliance’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.18 earnings per share.

Several equities research analysts have issued reports on the stock. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Loop Capital assumed coverage on shares of Walgreens Boots Alliance in a research note on Thursday, August 24th. They set a “buy” rating and a $95.00 target price on the stock. Finally, UBS AG reaffirmed a “buy” rating and set a $96.00 target price (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $91.81.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 13.50% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the business. Pathstone Family Office LLC increased its stake in Walgreens Boots Alliance by 226.6% during the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock worth $1,969,000 after purchasing an additional 818 shares during the period. Hudock Capital Group LLC increased its stake in Walgreens Boots Alliance by 0.4% during the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 5 shares during the period. Westside Investment Management Inc. increased its stake in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares during the period. Tarbox Group Inc. increased its stake in Walgreens Boots Alliance by 288.3% during the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after purchasing an additional 1,006 shares during the period. Finally, Reilly Financial Advisors LLC increased its stake in Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Institutional investors own 60.18% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance, Inc. (WBA) Expected to Announce Quarterly Sales of $29.93 Billion” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/09/15/walgreens-boots-alliance-inc-wba-expected-to-announce-quarterly-sales-of-29-93-billion-2.html.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 81.91 on Friday. The stock has a market cap of $87.65 billion, a P/E ratio of 20.68 and a beta of 1.26. The company’s 50-day moving average is $81.15 and its 200-day moving average is $82.02. Walgreens Boots Alliance has a 1-year low of $75.18 and a 1-year high of $89.69.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were issued a $0.40 dividend. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 1.95%. The ex-dividend date was Wednesday, August 16th. Walgreens Boots Alliance’s payout ratio is 40.30%.

Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its shares are undervalued.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.